Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571536
PUBLISHER: Grand View Research | PRODUCT CODE: 1571536
China Diabetes Devices Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End-use, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
China Diabetes Devices Market Growth & Trends:
The China diabetes devices market size is anticipated to reach USD 3.18 billion by 2030 and is anticipated to grow at a CAGR of 9.11% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing prevalence of diabetes, attributed to lifestyle changes, urbanization, and an aging population. For instance, according to the International Federation of Diabetes, in 2021 there were about 140.86 million diabetes cases in China, which are further estimated to reach 164.06 million by 2030. This surge in diabetes cases has created a substantial demand for advanced diabetes management tools, including blood glucose monitoring devices, insulin delivery systems, and continuous glucose monitors (CGMs).
Technological advancements and innovation are further expanding market by addressing the diverse needs of its large population. Innovations in diabetes care devices, such as continuous glucose monitors (CGMs), smart insulin pens, and wearable insulin pumps, have made them more user-friendly, portable, and efficient. These devices now offer features like real-time glucose monitoring, smartphone connectivity, and data analytics, enabling patients to better manage their condition with minimal effort and greater accuracy. Moreover, advancements in sensor technology and artificial intelligence have led to more precise and non-invasive glucose monitoring solutions, which enhance patient comfort and compliance. The development of cost-effective devices tailored to the needs of the Chinese market, such as locally manufactured blood glucose meters and low-cost test strips, has made diabetes management more accessible to a broader segment of the population, including those in rural and underserved areas.
The market growth market is further significantly fueled by increasing awareness about diabetes and its management among both patients and healthcare professionals. Public health campaigns, educational programs, and community outreach efforts by the government and non-governmental organizations have played a crucial role in raising awareness about the importance of early diagnosis, regular monitoring, and effective management of diabetes. Furthermore, companies operating in the diabetes devices market are working to improve their product offerings by upgrading their products, leveraging important cooperative drives, as well as considering acquisitions and government approvals these efforts are aimed at expanding their customer base and gaining a larger share of the market.
China Diabetes Devices Market Report Highlights:
- Based on type segment, the insulin delivery devices segment dominated the market with a share of 54.2% in 2023 and is further anticipated to grow at the fastest CAGR from 2024 to 2030 due to convenience and ease of use of insulin pens compared to traditional syringes
- Based on distribution channel, the hospital pharmacies segment held the largest revenue share of more than 50% in 2023 due to the important role of hospital pharmacies as primary access points for patients undergoing diabetes care in these healthcare facilities
- Retail pharmacies are expected to grow ta fastest CAGR from 2024 to 2030 owing to the accessibility and convenience offered by retail pharmacies to patients
- Based on end use, the hospitals segment held a majority share of the market of 40.8% in 2023, driven by the increasing patient preference for hospital settings and favorable government healthcare policies
- The diagnostic centers segment is expected to witness a significant CAGR of over 9.7% during the forecast period. This can be attributed to the increasing focus on early disease detection and prevention in the country's population
Product Code: GVR-4-68040-458-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Distribution channel
- 1.2.3. End use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Distribution Channel outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. China Diabetes Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of diabetes
- 3.2.1.2. Technological Innovations & Product Advancements
- 3.2.1.3. Growing focus on diabetes care
- 3.2.2. Market restraint analysis
- 3.2.2.1. Stringent regulatory policies and regulations
- 3.2.2.2. High cost of devices
- 3.2.1. Market driver analysis
- 3.3. China Diabetes Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. China Diabetes Devices Market: Type Estimates & Trend Analysis
- 4.1. Type Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. China Diabetes Devices Market by Type Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Blood Glucose Monitoring Devices
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Self-Monitoring Devices
- 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.2. Blood Glucose Meters
- 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.3. Testing Strips
- 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2.4. Lancets
- 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Continuous Glucose-Monitoring Devices
- 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3.2. Sensors
- 4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3.3. Transmitters
- 4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3.4. Receiver
- 4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Insulin Delivery Devices
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.2. Insulin Pumps
- 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.3. Insulin Pens
- 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.4. Insulin Syringes
- 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.5. Insulin Jet injectors
- 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. China Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
- 5.1. Distribution Channel Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Suadi Arabia Diabetes Devices Market by Distribution Channel Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Hospital Pharmacies
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Retail Pharmacies
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Diabetes Clinics/Centers
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Online Pharmacies
- 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.9. Others
- 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. China Diabetes Devices Market: End Use Estimates & Trend Analysis
- 6.1. End Use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. China Diabetes Devices Market by End Use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Diagnostic Centers
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Homecare
- 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Key Company Market Share Analysis, 2023
- 7.4. Company Position Analysis, 2023
- 7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
- 7.6. Company Profiles
- 7.6.1. Abbott
- 7.6.1.1. Company overview
- 7.6.1.2. Financial performance
- 7.6.1.3. Product benchmarking
- 7.6.1.4. Strategic initiatives
- 7.6.2. F. Hoffmann-La Roche Ltd
- 7.6.2.1. Company overview
- 7.6.2.2. Financial performance
- 7.6.2.3. Product benchmarking
- 7.6.2.4. Strategic initiatives
- 7.6.3. Medtronic
- 7.6.3.1. Company overview
- 7.6.3.2. Financial performance
- 7.6.3.3. Product benchmarking
- 7.6.3.4. Strategic initiatives
- 7.6.4. Dexcom, Inc.
- 7.6.4.1. Company overview
- 7.6.4.2. Financial performance
- 7.6.4.3. Product benchmarking
- 7.6.4.4. Strategic initiatives
- 7.6.5. BD
- 7.6.5.1. Company overview
- 7.6.5.2. Financial performance
- 7.6.5.3. Product benchmarking
- 7.6.5.4. Strategic initiatives
- 7.6.6. Ascensia Diabetes Care Holdings AG
- 7.6.6.1. Company overview
- 7.6.6.2. Financial performance
- 7.6.6.3. Product benchmarking
- 7.6.6.4. Strategic initiatives
- 7.6.7. Novo Nordisk A/S
- 7.6.7.1. Company overview
- 7.6.7.2. Financial performance
- 7.6.7.3. Product benchmarking
- 7.6.7.4. Strategic initiatives
- 7.6.8. AstraZeneca
- 7.6.8.1. Company overview
- 7.6.8.2. Financial performance
- 7.6.8.3. Product benchmarking
- 7.6.8.4. Strategic initiatives
- 7.6.9. Sanofi
- 7.6.9.1. Company overview
- 7.6.9.2. Financial performance
- 7.6.9.3. Product benchmarking
- 7.6.9.4. Strategic initiatives
- 7.6.10. Sinocare
- 7.6.10.1. Company overview
- 7.6.10.2. Financial performance
- 7.6.10.3. Product benchmarking
- 7.6.10.4. Strategic initiatives
- 7.6.1. Abbott
Product Code: GVR-4-68040-458-7
List of Tables
- Table 1. List of secondary sources
- Table 2. List of abbreviation
- Table 3. China diabetes devices market, by type, 2018 - 2030 (USD Million)
- Table 4. China diabetes devices market, by end use, 2018 - 2030 (USD Million)
- Table 5. China diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 China diabetes devices market: Market outlook
- Fig. 9 China diabetes devices market competitive insights
- Fig. 10 Parent market outlook
- Fig. 11 Related/ancillary market outlook
- Fig. 12 Penetration and growth prospect mapping
- Fig. 13 Industry value chain analysis
- Fig. 14 China diabetes devices market driver impact
- Fig. 15 China diabetes devices market restraint impact
- Fig. 16 China diabetes devices market: type movement analysis
- Fig. 17 China diabetes devices market: type outlook and key takeaways
- Fig. 18 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
- Fig. 19 Self-monitoring devices market estimates and forecast, 2018 - 2030
- Fig. 20 Blood glucose meters market estimates and forecast, 2018 - 2030
- Fig. 21 Testing strips market estimates and forecast, 2018 - 2030
- Fig. 22 Lancets market estimates and forecast, 2018 - 2030
- Fig. 23 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
- Fig. 24 Sensors market estimates and forecast, 2018 - 2030
- Fig. 25 Transmitters market estimates and forecast, 2018 - 2030
- Fig. 26 Receivers market estimates and forecast, 2018 - 2030
- Fig. 27 Insulin delivery devices market estimates and forecast, 2018 - 2030
- Fig. 28 Insulin pumps market estimates and forecast, 2018 - 2030
- Fig. 29 Insulin pens market estimates and forecast, 2018 - 2030
- Fig. 30 Insulin syringes market estimates and forecast, 2018 - 2030
- Fig. 31 Insulin jet injectors market estimates and forecast, 2018 - 2030
- Fig. 32 China diabetes devices market: distribution channel movement analysis
- Fig. 33 China diabetes devices market: distribution channel outlook and key takeaways
- Fig. 34 Hospital pharmacies market estimates and forecast, 2018 - 2030
- Fig. 35 Retail pharmacies market estimates and forecast, 2018 - 2030
- Fig. 36 Diabetes clinics/centers market estimates and forecast, 2018 - 2030
- Fig. 37 Online pharmacies market estimates and forecast, 2018 - 2030
- Fig. 38 Others market estimates and forecast, 2018 - 2030
- Fig. 39 China diabetes devices market: end use movement analysis
- Fig. 40 China diabetes devices market: end use outlook and key takeaways
- Fig. 41 Hospitals market estimates and forecast, 2018 - 2030
- Fig. 42 Diagnostic centers market estimates and forecast, 2018 - 2030
- Fig. 43 Homecare market estimates and forecast, 2018 - 2030
- Fig. 44 Participant categorization- China diabetes devices market
- Fig. 45 Market share of key market players- China diabetes devices market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.